T. Waid

D. Dadhania, S. Seshan, V. Nickeleit, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Impact of human leukocyte antigen and calculated panel reactive antibody on BK viremia in kidney transplant recipients: A single‐center experience and literature review

R. Gedaly, X. Mei, A. El-Husseini, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study Group.

M. Pescovitz, D. Min, T. Pruett, 1996, Transplantation.

First‐in‐Human Study of the Safety and Efficacy of TOL101 Induction to Prevent Kidney Transplant Rejection

S. Miller, S. Flechner, D. Getts, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Safety and tolerability of neoral vs sandimmune: 1-year data in primary renal allograft recipients

M. Pescovitz, D. Min, D. Hricik, 1996 .

Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study Group.

M. Pescovitz, D. Min, D. Hricik, 1996, Transplantation proceedings.

T10B9 MONOCLONAL ANTIBODY: SHORT ACTING NON-STIMULATING MONOCLONAL ANTIBODY THT SPARES GAMMA DELTA T-CELLS AND TREATS AND PREVENTS CELLULAR REJECTION.: 1954

M. Siemionow, Stephen P. A. Brown, T. Waid, 2008 .

Impact of Acute Rejection Episodes on Long‐Term Graft Survival Following Simultaneous Kidney‐Pancreas Transplantation

S. Tuteja, D. Davies, T. Johnston, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure.

D. Stablein, R. Stratta, T. Johnston, 2001, Transplantation proceedings.

Conversion From Cyclosporine to Tacrolimus in Patients at Risk for Chronic Renal Allograft Failure: 60-Month Results of the CRAF Study

A. Henning, D. Conti, M. First, 2008, Transplantation.

T10B9 (MEDI-500) mediated immunosuppression: studies on the mechanism of action.

S. Barve, J. Thompson, B. Lucas, 1996, Clinical transplantation.

Induction immunotherapy in heart transplantation with T10B9.1A-31: a phase I study.

J. Thompson, S. Brown, T. Waid, 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial.

S. Mulgaonkar, M. Weir, L. Chan, 2017, Transplantation.

Transplantation of Pediatric En Bloc Cadaver Kidneys into Adult Recipients: A Single-Center Experience

T. Johnston, D. Ranjan, B. Lucas, 2002, The American surgeon.

Treatment of acute cellular kidney allograft rejection with T10B9.1A-31A anti T-cell monoclonal antibody.

G. Janossy, J. Thompson, B. Lucas, 1989, Transplantation proceedings.

TREATMENT OF ACUTE CELLULAR REJECTION WITH T10B9.1A‐31 OR OKT3 IN RENAL ALLOGRAFT RECIPIENTS1

Stephen P. A. Brown, L. Munch, B. Lucas, 1992, Transplantation.

Safety and tolerability of cyclosporine microemulsion versus cyclosporine: two-year data in primary renal allograft recipients: a report of the Neoral Study Group.

M. Pescovitz, D. Min, D. Hricik, 1997, Transplantation.

The safety and tolerability of cyclosporine emulsion versus cyclosporine in a randomized, double-blind comparison in primary renal allograft recipients

M. Pescovitz, D. Min, D. Hricik, 1996 .

T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection.

G. Janossy, D. Ježek, S. Cammisuli, 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.